688136 科興製藥
按盤價 
23.600 +3.050 (+14.842%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.465 | 9.189 | 1.931 | -11.081 | -4.856 |
| 總資產報酬率 ROA (%) | 3.697 | 4.647 | 1.017 | -6.143 | -3.013 |
| 投入資產回報率 ROIC (%) | 4.074 | 5.141 | 1.115 | -6.734 | -3.341 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.096 | 63.366 | 68.689 | 70.791 | 75.365 |
| 營業利潤率 (%) | 24.144 | 10.959 | 4.492 | -20.351 | -10.530 |
| 息稅前利潤/營業總收入 (%) | 29.436 | 13.181 | 6.948 | -18.179 | -9.434 |
| 淨利潤/營業總收入 (%) | 21.820 | 9.957 | 1.923 | -15.527 | -7.054 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -67.926 | 32.915 | 109.898 | 104.758 | 100.529 |
| 價值變動淨收益/利潤總額(%) | 168.503 | 65.849 | -34.906 | -2.602 | 2.282 |
| 營業外收支淨額/利潤總額(%) | 0.325 | -1.455 | -11.068 | 1.476 | 0.363 | 償債能力分析 |
| 流動比率 (X) | 1.345 | 1.574 | 1.453 | 1.692 | 2.617 |
| 速動比率 (X) | 1.223 | 1.438 | 1.293 | 1.406 | 2.231 |
| 資產負債率 (%) | 50.490 | 50.404 | 48.162 | 46.198 | 42.938 |
| 帶息債務/全部投入資本 (%) | 43.575 | 43.922 | 42.197 | 40.121 | 35.786 |
| 股東權益/帶息債務 (%) | 124.207 | 125.376 | 134.890 | 146.148 | 175.534 |
| 股東權益/負債合計 (%) | 98.055 | 98.312 | 107.349 | 116.120 | 133.080 |
| 利息保障倍數 (X) | 5.647 | 5.540 | 2.393 | -7.340 | -8.318 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 168.654 | 123.799 | 95.928 | 87.480 | 92.144 |
| 存貨周轉天數 (天) | 88.937 | 90.012 | 136.135 | 195.562 | 211.192 |
| 備註： | 即時報價更新時間為 24/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
